JNCE NASDAQ
Jounce Therapeutics, Inc.
1W: -2.6%
1M: -1.1%
3M: +55.4%
1Y: -64.0%
3Y: -64.8%
5Y: -90.7%
$1.88
Last traded 2023-05-05 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$82M
Revenue
+204.8% YoY
$-51M
Net Income
+16.0% YoY
$-30M
Free Cash Flow
+64.5% YoY
100.0%
Gross Margin
61.4%
Op. Margin
62.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-25.0%
ROA-21.9%
ROIC-1149.6%
Valuation
P/E-1.9
P/B0.5
EV/EBITDA2.4
Leverage
Debt/Equity0.05
Current Ratio8.37
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-0.20
Beneish M2718396.30